Humana Inc. (HUM)
$
233.13
+3.05 (1.31%)
Key metrics
Financial statements
Free cash flow per share
19.7749
Market cap
27.5 Billion
Price to sales ratio
0.2286
Debt to equity
0.7496
Current ratio
1.9078
Income quality
1.6758
Average inventory
0
ROE
0.1001
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Humana Inc., along with its subsidiaries, is a prominent health and well-being company operating in the United States through three distinct segments: Retail, Group and Specialty, and Healthcare Services. The company reported depreciation and amortization expenses of $968,000,000.00 reflecting the wear and tear of its assets. Additionally, the net total of other income and expenses is -$935,000,000.00 highlighting its engagement in non-core financial activities. The company reported an income before tax of $1,627,000,000.00 showcasing its pre-tax profitability, while incurring an interest expense of $660,000,000.00 reflecting its debt servicing obligations. The cost of revenue for the company is $0.00 illustrating its production and operational expenses. Humana offers a range of medical and supplemental benefit plans tailored for individuals and maintains contracts with the Centers for Medicare and Medicaid Services to manage the Limited Income Newly Eligible Transition prescription drug plan program. Furthermore, it collaborates with various states to deliver Medicaid, dual eligible, and long-term support services benefits, as well as providing commercial fully insured medical and specialty health insurance benefits that include dental, vision, and other supplemental options. The company also administers services solely for its employer groups and individual clients, alongside military services like the TRICARE T2017 East Region contract. With a substantial membership base, as of December 31, 2021, the company had around 17 million members in medical benefit plans and approximately 5 million in specialty products. In terms of market performance, the stock is priced at $230.08 positioning it in the higher-end market. It shows a high average trading volume of 1,750,542.00 indicating strong liquidity, while maintaining a mid-range market capitalization of $28,137,159,090.00 categorizing the company as a steady performer. As a key player in the Medical - Healthcare Plans industry, Humana contributes significantly to the overall market landscape and belongs to the Healthcare sector, driving innovation and growth. Through its expansive offerings and substantial member base, Humana Inc. continues to impact the health and well-being of millions while leveraging its financial performance and market position to sustain its growth objectives.
Is Humana Inc. (HUM) a good investment?
Investing in Humana Inc. (HUM) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B+, with a Bearish outlook. Always conduct your own research before investing.
What is Humana Inc. (HUM)'s stock forecast?
Analysts predict Humana Inc. stock to fluctuate between $212.45 (low) and $406.46 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Humana Inc.'s market capitalization?
As of 2025-05-30, Humana Inc.'s market cap is $28,137,159,090, based on 120,693,000 outstanding shares.
How does Humana Inc. compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., Humana Inc. has a Lower Market-Cap, indicating a difference in performance.
Does Humana Inc. pay dividends?
Humana Inc. pays dividends. The current dividend yield is 1.52%, with a payout of $0.89 per share.
How can I buy Humana Inc. (HUM) stock?
To buy Humana Inc. (HUM) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for HUM. Place an order (Market, Limit, etc.).
What is the best time to invest in Humana Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Has Humana Inc. stock ever split?
Humana Inc.'s last stock split was 3:2 on 1991-08-01.
How did Humana Inc. perform in the last earnings report?
Revenue: $117,761,000,000 | EPS: $10.01 | Growth: -50.17%.
Where can I find Humana Inc.'s investor relations reports?
Visit https://www.humana.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Humana Inc.?
You can explore historical data from here
What is the all-time high and low for Humana Inc. stock?
All-time high: $571.30 (2022-11-03) | All-time low: $212.45 (2025-05-15).
What are the key trends affecting Humana Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
accessnewswire.com
NEW YORK CITY, NY / ACCESS Newswire / May 27, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
accessnewswire.com
NEW YORK CITY, NY / ACCESS Newswire / May 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
businesswire.com
LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM), announced today a $50,000 contribution to advance sustained recovery efforts in Kentucky communities devastated by the most recent wave of severe storms and tornadoes. On Friday, May 16, powerful storms swept across the state, causing widespread destruction—particularly in Laurel and Pulaski Counties. The city of London experienced considerable damage, and residents across the region continue.
investopedia.com
U.S. equities edged higher at midday as the market considered the impact of the Republican tax and spending bill that passed by the narrowest of margins this morning. The Nasdaq, Dow Jones Industrial Average, and S&P 500 all rose.
investopedia.com
Shares of Humana (HUM) and other health insurers fell Thursday after the Centers for Medicare & Medicaid Services said it plans to take a more "aggressive" approach to auditing Medicare Advantage plans.
barrons.com
CMS will begin to audit all eligible MA contracts every payment year, the federal agency said Wednesday.
businesswire.com
LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. for the past 44 years, is proud to announce that Tiffany Benjamin, the foundation's CEO, has been named to the inaugural TIME100 Philanthropy list, celebrating the singular figures shaping the future of giving. “I am deeply honored to be recognized by TIME100 Philanthropy for the work of the Humana Foundation and our nonprofit partners in advancing health equity for underserved and marginalized communi.
accessnewswire.com
NEW YORK CITY, NY / ACCESS Newswire / May 19, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
accessnewswire.com
NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
prnewswire.com
NEW YORK , May 12, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE: HUM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
See all news
